[1]
S. Perrone, “Is there a better therapeutic time window from diagnosis to treatment elderly acute myeloid leukemia patients receiving hypomethylating agents?”, Mediterr J Hematol Infect Dis, vol. 16, no. 1, p. e2024055, Jun. 2024.